A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Neuvosyn Laboratories, LLC
- Target Recruit Count
- 300
- Registration Number
- NCT05712421
- Locations
- 🇺🇸
Neuvosyn Investigational Site, Stafford, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath